<DOC>
	<DOC>NCT00823199</DOC>
	<brief_summary>This is a four week open label trial of ALLOPURINOL to the treatment regime of ten (10) poorly responsive patients with schizophrenia, monitoring their response and side-effects. No change in medication is required.</brief_summary>
	<brief_title>An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Subjects with schizophrenia and poor response (no prospect of discharge because of symptoms) Over 65 Renal or liver disease Diabetes Hypertension Taking thiazides or ACE inhibitors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>